US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist
  • 0.2118
  • -0.0017-0.80%
Trading May 8 10:08 ET
8.85MMarket Cap-0.15P/E (TTM)

Carisma Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
31.59%19.63M
-14.83%3.65M
-11.55%3.39M
158.34%9.2M
4.75%3.4M
51.71%14.92M
14.96%4.29M
48.45%3.83M
31.71%3.56M
294.53%3.24M
Operating revenue
31.59%19.63M
-14.83%3.65M
-11.55%3.39M
158.34%9.2M
4.75%3.4M
51.71%14.92M
14.96%4.29M
48.45%3.83M
31.71%3.56M
294.53%3.24M
Cost of revenue
Gross profit
Operating expense
-21.07%81.81M
-19.56%21.51M
-36.84%16.53M
-14.92%20.87M
-12.62%22.91M
57.05%103.65M
40.34%26.74M
35.40%26.17M
47.42%24.53M
138.80%26.22M
Selling and administrative expenses
-25.02%22.14M
-19.03%5.93M
-21.40%5.2M
-7.44%5.56M
-43.13%5.45M
214.83%29.53M
654.27%7.32M
75.50%6.62M
147.81%6.01M
333.02%9.57M
-General and administrative expense
-25.02%22.14M
-19.03%5.93M
-21.40%5.2M
-7.44%5.56M
-43.13%5.45M
214.83%29.53M
654.27%7.32M
75.50%6.62M
147.81%6.01M
333.02%9.57M
Research and development costs
-19.50%59.67M
-19.76%15.58M
-42.07%11.33M
-17.34%15.31M
4.93%17.46M
30.92%74.13M
7.37%19.42M
25.67%19.55M
30.30%18.52M
89.81%16.64M
Operating profit
29.92%-62.18M
20.47%-17.86M
41.17%-13.14M
44.34%-11.67M
15.07%-19.51M
-57.99%-88.73M
-46.52%-22.45M
-33.39%-22.34M
-50.47%-20.97M
-126.19%-22.97M
Net non-operating interest income expense
-12.09%1.7M
-83.01%220K
-53.03%442K
-56.84%508K
136.02%532K
161.56%1.94M
249.37%1.3M
203.63%941K
252.66%1.18M
-146.58%-1.48M
Non-operating interest income
-12.09%1.7M
----
----
----
----
--1.94M
----
----
----
----
Total other finance cost
----
----
53.03%-442K
56.84%-508K
-136.02%-532K
----
----
-203.63%-941K
-252.66%-1.18M
146.58%1.48M
Other net income (expense)
95.62%-84K
0
84.92%-84K
Gain on sale of security
----
----
----
----
----
95.62%-84K
--0
----
----
84.92%-84K
Income before tax
30.39%-60.48M
16.64%-17.64M
40.65%-12.7M
43.59%-11.16M
22.64%-18.98M
-41.90%-86.88M
-26.38%-21.16M
-16.78%-21.4M
-33.27%-19.79M
-116.88%-24.53M
Income tax
0
0
0
0
88K
109K
Net income
30.39%-60.48M
15.86%-17.64M
40.65%-12.7M
43.84%-11.16M
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
Net income continuous Operations
30.39%-60.48M
15.86%-17.64M
40.65%-12.7M
43.84%-11.16M
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
Minority interest income
Net income attributable to the parent company
30.39%-60.48M
15.86%-17.64M
40.65%-12.7M
43.84%-11.16M
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
30.39%-60.48M
15.86%-17.64M
40.65%-12.7M
43.84%-11.16M
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
Basic earnings per share
43.63%-1.46
12.50%-0.42
41.51%-0.31
44.90%-0.27
76.17%-0.46
-70.29%-2.59
-15.43%-0.48
-16.41%-0.53
-32.84%-0.49
-586.81%-1.93
Diluted earnings per share
43.63%-1.46
12.50%-0.42
41.51%-0.31
44.90%-0.27
76.17%-0.46
-70.29%-2.59
-15.43%-0.48
-16.41%-0.53
-32.84%-0.49
-586.81%-1.93
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 31.59%19.63M-14.83%3.65M-11.55%3.39M158.34%9.2M4.75%3.4M51.71%14.92M14.96%4.29M48.45%3.83M31.71%3.56M294.53%3.24M
Operating revenue 31.59%19.63M-14.83%3.65M-11.55%3.39M158.34%9.2M4.75%3.4M51.71%14.92M14.96%4.29M48.45%3.83M31.71%3.56M294.53%3.24M
Cost of revenue
Gross profit
Operating expense -21.07%81.81M-19.56%21.51M-36.84%16.53M-14.92%20.87M-12.62%22.91M57.05%103.65M40.34%26.74M35.40%26.17M47.42%24.53M138.80%26.22M
Selling and administrative expenses -25.02%22.14M-19.03%5.93M-21.40%5.2M-7.44%5.56M-43.13%5.45M214.83%29.53M654.27%7.32M75.50%6.62M147.81%6.01M333.02%9.57M
-General and administrative expense -25.02%22.14M-19.03%5.93M-21.40%5.2M-7.44%5.56M-43.13%5.45M214.83%29.53M654.27%7.32M75.50%6.62M147.81%6.01M333.02%9.57M
Research and development costs -19.50%59.67M-19.76%15.58M-42.07%11.33M-17.34%15.31M4.93%17.46M30.92%74.13M7.37%19.42M25.67%19.55M30.30%18.52M89.81%16.64M
Operating profit 29.92%-62.18M20.47%-17.86M41.17%-13.14M44.34%-11.67M15.07%-19.51M-57.99%-88.73M-46.52%-22.45M-33.39%-22.34M-50.47%-20.97M-126.19%-22.97M
Net non-operating interest income expense -12.09%1.7M-83.01%220K-53.03%442K-56.84%508K136.02%532K161.56%1.94M249.37%1.3M203.63%941K252.66%1.18M-146.58%-1.48M
Non-operating interest income -12.09%1.7M------------------1.94M----------------
Total other finance cost --------53.03%-442K56.84%-508K-136.02%-532K---------203.63%-941K-252.66%-1.18M146.58%1.48M
Other net income (expense) 95.62%-84K084.92%-84K
Gain on sale of security --------------------95.62%-84K--0--------84.92%-84K
Income before tax 30.39%-60.48M16.64%-17.64M40.65%-12.7M43.59%-11.16M22.64%-18.98M-41.90%-86.88M-26.38%-21.16M-16.78%-21.4M-33.27%-19.79M-116.88%-24.53M
Income tax 000088K109K
Net income 30.39%-60.48M15.86%-17.64M40.65%-12.7M43.84%-11.16M22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M
Net income continuous Operations 30.39%-60.48M15.86%-17.64M40.65%-12.7M43.84%-11.16M22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M
Minority interest income
Net income attributable to the parent company 30.39%-60.48M15.86%-17.64M40.65%-12.7M43.84%-11.16M22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 30.39%-60.48M15.86%-17.64M40.65%-12.7M43.84%-11.16M22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M
Basic earnings per share 43.63%-1.4612.50%-0.4241.51%-0.3144.90%-0.2776.17%-0.46-70.29%-2.59-15.43%-0.48-16.41%-0.53-32.84%-0.49-586.81%-1.93
Diluted earnings per share 43.63%-1.4612.50%-0.4241.51%-0.3144.90%-0.2776.17%-0.46-70.29%-2.59-15.43%-0.48-16.41%-0.53-32.84%-0.49-586.81%-1.93
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
YETI Holdings
YETI
28.650
New Fortress Energy
NFE
6.070
Workday
WDAY
255.150
4
Enerpac Tool
EPAC
42.414
5
Ermenegildo Zegna NV
ZGN
8.093
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Earnings Season Underway

Earnings season is here. What to know?